MOLECULAR PARTNERS AG (MLLCF)
Clinical trial NCT03323346 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-12-31 → 2025-12-30 3. primary completion date: 2025-12-31 → 2025-10-30 4. enrollment: 150 → 9 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (61%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (25%) **Content type:** Clinical